News argenx SE

Equities

ARGX

NL0010832176

Biotechnology & Medical Research

Real-time Euronext Bruxelles Other stock markets 05:58:36 2026-04-20 EDT			5-day change	1st Jan Change
711.80 ^EUR	-0.84%		+5.17%	-0.67%

04-18	Argenx SE Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP	CI
04-18	Argenx brings neuromuscular leadership to AAN 2026 with new data supporting broader Vyvgart use across MG and CIDP	RE

All News

04-18	Argenx SE Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP	CI
04-18	Argenx brings neuromuscular leadership to AAN 2026 with new data supporting broader Vyvgart use across MG and CIDP	RE
04-18	Argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP	GL
04-16	Argenx's Vyvgart Seen Gaining More Patients in Coming Months, Wedbush Says	MT
04-16	European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading	MT
04-15	European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading	MT
04-15	ARGENX : Goldman Sachs keeps its Buy rating	ZD
04-13	Lineage Cell Therapeutics, Inc. Announces Formation of Scientific Advisory Board and Executive Appointment	CI
04-07	European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading	MT
04-02	Oppenheimer Adjusts Price Target on Argenx to $1,014 From $1,060, Maintains Outperform Rating	MT
04-01	ARGENX : UBS gives a Neutral rating	ZD
04-01	ARGENX : Goldman Sachs reaffirms its Buy rating	ZD
03-30	ARGENX : Receives a Buy rating from Barclays	ZD
03-20	Argenx SE Announces Retirement of Jim Daly as Non-Executive Director and Chair of the Commercialization Committee, Effective May 6, 2026	CI
03-20	Argenx announces Annual General Meeting of Shareholders on May 6, 2026	GL
03-19	Argenx : argenx announces Annual General Meeting of Shareholders on May 6, 2026	PU
03-14	How are different indices influenced?
03-11	Deutsche Bank Upgrades Argenx to Buy, Boosts PT	MT
03-06	Argenx SE Presents New Data and Pipeline Updates At 2026 AAN Annual Meeting	CI
03-06	Argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline	GL
03-05	European Equities Traded in the US as American Depositary Receipts Slide in Thursday Trading	MT
03-05	ARGENX : Gets a Buy rating from JP Morgan	ZD
02-27	RBC Capital Adjusts argenx SE ADR PT to $890 From $925, Maintains Outperform Rating	MT
02-27	Inflation Bites Back
02-27	ARGENX : Barclays remains its Buy rating	ZD